REFERENCES

  1. VRAYLAR [package insert]. North Chicago, IL: AbbVie Inc.; 2024.
  2. Data on File, AbbVie Inc.
  3. Clayton AH, Sachs GS, Adams JL, et al. Poster presented at: Psych Congress; New Orleans, LA; September 17-20,2022.
  4. Durgam S, Earley W, Lipschitz A, et al. Am J Psychiatry. 2016;173(3):271-281.
  5. Earley W, Burgess MV, Rekeda L, et al. Am J Psychiatry. 2019;176(6):439-448.
  6. Earley WR, Burgess MV, Khan B, et al. Bipolar Disord. 2020;22(4):372-384.
  7. Yatham LN, Vieta E, McIntyre RS, et al. Prim Care Companion CNS Disord. 2020;22(5):20m02611.
  8. Rosa AR, Sánchez-Moreno J, Martínez-Aran A, et al. Clin Pract Epidemiol Ment Health. 2007;3(5):1-8.
  9. Calabrese JR, Keck PE Jr, Starace A, et al. J Clin Psychiatry. 2015;76(3):284-292.
  10. Durgam S, Starace A, Li D, et al. Bipolar Disord. 2015;17(1):63-75.
  11. Sachs GS, Greenberg WM, Starace A, et al. J Affect Disord. 2015;174:296-302.
  12. Vieta E, Durgam S, Lu K, et al. Eur Neuropsychopharmacol. 2015;25(11):1882-1891.
  13. Durgam S, Starace A, Li D, et al. Schizophr Res. 2014;152(2-3):450-457.
  14. Durgam S, Cutler AJ, Lu K, et al. J Clin Psychiatry. 2015;76(12):e1574-e1582.
  15. Kane JM, Zukin S, Wang Y, et al. J Clin Psychopharmacol. 2015;35(4):367-373.
  16. Durgam S, Earley W, Li R, et al. Schizophr Res. 2016;176(2-3):264-271.
  17. Citrome L, Yatham LN, Patel MD, Barabássy Á, Hankinson A, Earley WR. J Affect Disord. 2021;288:191-198.
  18. Earley W, Durgam S, Lu K, et al. J Affect Disord. 2017;215:205-212.
  19. Earley W, Durgam S, Lu K, Laszlovszky I, Debelle M, Kane JM. Int Clin Psychopharmacol. 2017;32(6):319-328.
  20. Lieberman JA. CNS Drugs. 2004;18(4):251-267.
  21. Stahl SM, Laredo S, Morrissette D. Ther Adv Psychopharmacol. 2020;10:1-11.
  22. McIntyre RS, Patel MD, Masand PS, et al. Curr Med Res Opin. 2021;37(1):135-144. 
  23. Hirschfeld RMA, Cass AR, Holt DCL, Carlson CA. J Am Board Fam Pract. 2005;18(4):233-239.
  24. Hirschfeld RM. J Affect Disord. 2014;169(suppl 1);S12-S16.
  25. Awad AG, Rajagopalan K, Bolge SC, McDonnell DD. Prim Care Companion J Clin Psychiatry. 2007;9(3):195-202.
  26. Hu J, Mansur R, McIntyre RS. Prim Care Companion CNS Disord. 2014;16(2).
  27. Montgomery SA, Asberg M. Br J Psychiatry. 1979;134(4):382-389.
  28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. DSM-5. 5th ed. American Psychiatric Association; 2013.
  29. Young RC, Biggs JT, Ziegler VE, Meyer DA. Br J Psychiatry. 1978;133:429-435.
  30. McIntyre RS, Soczynska JK, Cha DS, et al. J Affect Disord. 2015;172:259-264.
  31. Fusco N, Sils B, Graff JS, Kistler K, Ruiz K. Cost-sharing and adherence, clinical outcomes, health care utilization, and costs: A systemic literature review. J Manag Care Spec Pharm. 2023;29(1):4-16. doi:10.18553/jmcp.2022.21270
  32. Culpepper L. The diagnosis and treatment of bipolar disorder: decision-making in primary care. Prim Care Companion CNS Discord. 2014;16(3):PCC.13r01609
  33. Vieta E, Berk M, Schulze TG, et al. Bipolar disorders. Nat Rev Dis Primers. 2018;4:18008. Published 2018 Mar 8. doi:10.1038/nrdp.2018.8
  34. Miller CJ, Johnson SL, Kwapil TR, Carver CS. Three studies on self-report scales to detect bipolar disorder. J Affect Disord. 2011;128(3):199-210. doi:10.1016/j.jad.2010.07.012
  35. Sachs GS, Yeung PP, Rekeda L, Khan A, Adams JL, Fava M. Adjunctive cariprazine for the treatment of patients with major depressive disorder: a randomized, double-blind placebo-controlled phase 3 study. Am J Psychiatry. 2023;180(3):241-251. doi:10.1176/appi.ajp.20220504
  36. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR. 5th ed. American Psychiatric Association; 2022.